{
    "clinical_study": {
        "@rank": "151238", 
        "arm_group": [
            {
                "arm_group_label": "propofol (Group P)", 
                "arm_group_type": "Placebo Comparator", 
                "description": "The patients in Group P received 1 mg/kg propofol IV (over 15 sec) during anesthesia induction"
            }, 
            {
                "arm_group_label": "remifentanil and propofol (Group R)", 
                "arm_group_type": "Active Comparator", 
                "description": "Patients in Group R received remifentanil 1 \u00b5g/kg IV (over 60 sec) and 0.5 mg/kg propofol IV (over 15 sec)during anesthesia induction"
            }, 
            {
                "arm_group_label": "sevoflurane (Group S)", 
                "arm_group_type": "Active Comparator", 
                "description": "In Group S, sevoflurane was started at 6% for induction and continued at 1% until the electrical stimulus was delivered, at which time it was stopped."
            }
        ], 
        "brief_summary": {
            "textblock": "To compare the effectiveness of three different anesthetic regimens (propofol,\n      remifentanil-propofol and sevoflurane in ECT."
        }, 
        "brief_title": "Three Anaesthesic Method in Electroconvulsive Theraphy", 
        "completion_date": {
            "#text": "August 2011", 
            "@type": "Actual"
        }, 
        "condition": "Anesthesia", 
        "detailed_description": {
            "textblock": "The purpose of this study is to compare the effectiveness of three different anesthetic\n      regimens (propofol, remifentanil-propofol and sevoflurane) with respect to seizure duration,\n      postictal suppression index, early and midictal amplitude, hemodynamic variables and\n      recovery profiles in ECT."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Upremedicated ASA I-II (American Society of Anesthesiologists's physical status)\n             patients,\n\n          -  Patients scheduled for six ECT sessions for a variety of psychiatric conditions\n             (major depression, schizophrenia)\n\n        Exclusion Criteria:\n\n          -  Involuntary patient status\n\n          -  Patients with known or self-declared needle or mask phobia\n\n          -  Pregnancy\n\n          -  Asthma\n\n          -  Cerebrovascular disease,\n\n          -  History of myocardial infarction in the previous 6 months,\n\n          -  Atrial fibrillation or flutter,heart block,\n\n          -  A known or family history of reactions to the study drugs."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "65 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "39", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "December 14, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01759589", 
            "org_study_id": "Inonu University Anesthesia", 
            "secondary_id": "Inonu University"
        }, 
        "intervention": [
            {
                "arm_group_label": "propofol (Group P)", 
                "description": "1 mg/kg propofol IV (over 15 sec) during anesthesia induction", 
                "intervention_name": "Propofol", 
                "intervention_type": "Drug", 
                "other_name": "Intravenous anesthetic agent"
            }, 
            {
                "arm_group_label": "remifentanil and propofol (Group R)", 
                "description": "1 \u00b5g/kg IV (over 60 sec)remifentanil  and 0.5 mg/kg propofol IV (over 15 sec)during anesthesia induction", 
                "intervention_name": "Remifentanil and propofol", 
                "intervention_type": "Drug", 
                "other_name": "Opioid and intravenous anesthetic agent"
            }, 
            {
                "arm_group_label": "sevoflurane (Group S)", 
                "description": "Sevoflurane was started at 6% for induction and continued at 1% until the electrical stimulus was delivered", 
                "intervention_name": "Sevoflurane", 
                "intervention_type": "Drug", 
                "other_name": "Volatil anesthetic"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Anesthetics", 
                "Propofol", 
                "Sevoflurane", 
                "Remifentanil", 
                "Anesthetics, Intravenous"
            ]
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "No", 
        "keyword": "electroconvulsive therapy,sevoflurane,propofol,remifentanil", 
        "lastchanged_date": "December 31, 2012", 
        "location": {
            "facility": {
                "address": {
                    "city": "Malatya", 
                    "country": "Turkey", 
                    "zip": "44315"
                }, 
                "name": "Turgut Ozal Medical Center"
            }
        }, 
        "location_countries": {
            "country": "Turkey"
        }, 
        "number_of_arms": "3", 
        "official_title": "Sevoflurane Alone and Propofol With or Without Remifentanil in Electroconvulsive Therapy", 
        "overall_official": {
            "last_name": "Zekine Begec", 
            "role": "Study Director"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Turkey: Ethics Committee", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "May 2011", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "After anesthesia induction patients were administered electrical stimulation and seizure duration were measured.", 
            "measure": "Seizure duration", 
            "safety_issue": "Yes", 
            "time_frame": "The patients were observed about seizure up to ten minutes after electrical stimulation"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01759589"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Inonu University", 
            "investigator_full_name": "Zekine Begec", 
            "investigator_title": "Principal Investigator", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "results_reference": {
            "PMID": "15905753", 
            "citation": "Toprak HI, Gedik E, Bege\u00e7 Z, Ozt\u00fcrk E, Kaya B, Ersoy MO. Sevoflurane as an alternative anaesthetic for electroconvulsive therapy. J ECT. 2005 Jun;21(2):108-10."
        }, 
        "secondary_outcome": [
            {
                "description": "After anesthesia induction, patients were administered electrical stimulation. Then, postictal suppression index, a parameter that shows seizure quality, was determined from seizure records.", 
                "measure": "postictal suppression index", 
                "safety_issue": "Yes", 
                "time_frame": "completing seizure in one hour"
            }, 
            {
                "description": "The time from the end of succinylcholine administration to the recovery of spontaneous breathing, eye opening, and obeying of verbal commands were recorded.", 
                "measure": "Recovery parameters (spontaneous breathing, eye opening, and obeying of verbal commands)", 
                "safety_issue": "Yes", 
                "time_frame": "after seizure in one hour in operation room."
            }, 
            {
                "description": "During perioperative period:\nBefore administration of the study medications (t0), and at 1 (t1), 3 (t2), and 10 (t3) minutes after the seizure ended.", 
                "measure": "Hemodynamic variables", 
                "safety_issue": "Yes", 
                "time_frame": "Before administration of the study medications (t0), and at 1 (t1), 3 (t2), and 10 (t3) minutes after the seizure ended."
            }
        ], 
        "source": "Inonu University", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Inonu University", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "January 2011", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Crossover Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "December 2012"
    }
}